Vimpat 200 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FNL4L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,117
Award facts
- Contract value 100% obligated
- $2,117.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 200 mg tablets (60-count) on October 27, 2025, with a ceiling value of $2,117.02. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 28, 2025. The award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. VIMPAT (lacosamide) is an anticonvulsant medication used in neurological treatment regimens. The company's extensive portfolio of federal contract awards with DLA demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order reflects the company's ongoing role as a critical supplier within the Defense Health Agency's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FNL4L?
SPE2DR26FNL4L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DR26FNL4L worth?
The government has obligated $2,117 on SPE2DR26FNL4L.
Is contract SPE2DR26FNL4L an order under another contract?
Yes. SPE2DR26FNL4L is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNL4L competed?
The extent of competition for SPE2DR26FNL4L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award